Back to Search Start Over

Prognostic value of GPC5 polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients

Authors :
Fan Wang
Yutao Li
Zhengxing Li
Zixiu Zou
Yongming Lu
Chang Xu
ZongXu Zhao
HuaiZhou Wang
Yi Wang
Shicheng Guo
Li Jin
Jiucun Wang
Qiang Li
GengXi Jiang
Fan Xia
Bo Shen
Junjie Wu
Source :
Future Oncology. 18:3165-3177
Publication Year :
2022
Publisher :
Future Medicine Ltd, 2022.

Abstract

Background: GPC5 rs2352028 is associated with the risk of lung cancer, but its relationship with lung cancer prognosis is unclear. Materials & methods: The authors collected blood samples from 888 patients with lung cancer and used a Cox proportional hazards model to analyze the association between prognosis and GPC5 polymorphism rs2352028. Results: GPC5 rs2352028 C > T was associated with a better prognosis. Patients with CT genotype had longer overall survival than those with CC genotype. Additionally, older and early-stage patients with CT + TT genotype had a lower risk of death than those with CC genotype. Conclusion: GPC5 rs2352028 C > T may play a protective role in patients with lung cancer and GPC5 rs2352028 may be a potential genetic marker for lung cancer prognosis.

Details

ISSN :
17448301 and 14796694
Volume :
18
Database :
OpenAIRE
Journal :
Future Oncology
Accession number :
edsair.doi...........eea2f6e3520c3b1e3be797c9c3f418cf